Hemab Therapeutics
Biotech · Copenhagen, DK
Prophylactic therapeutics for bleeding and thrombotic disorders
Funding history
| Date | Round | Amount |
|---|
| Jan 2023 | Series B Copenhagen biotech Hemab Therapeutics raised $135M Series B led by Access Biotechnology. | $135M |
Investors
Access BiotechnologyAvoro VenturesDeep Track CapitalHealthCapNovo HoldingsRA Capital Management
Similar companies in Biotech
Explore funding flow on EquityFlow →